Valuation: EBOS Group Limited

Market Cap 3.53B 4.35B 2.44B 2.18B 2B 1.82B 3.45B 229B 23.97B 9.56B 122B 9.16B 8.96B 386B P/E 2027 *
15.1x
P/E 2028 * 13.1x
Enterprise Value 4.55B 5.59B 3.14B 2.8B 2.58B 2.34B 4.44B 294B 30.86B 12.3B 158B 11.79B 11.54B 496B EV / Sales 2027 *
0.32x
EV / Sales 2028 * 0.31x
Free-Float
90.8%
Yield 2027 *
5.51%
Yield 2028 * 6.04%
1 day-2.05%
1 week+2.44%
Current month+2.44%
1 month+11.46%
3 months-3.40%
6 months-1.82%
Current year-23.97%
1 week 20.96
Extreme 20.96000000
21.84
1 month 19.07
Extreme 19.07
21.84
Current year 18.45
Extreme 18.45
28.09
1 year 18.45
Extreme 18.45
29.5
3 years 18.45
Extreme 18.45
42.55
5 years 18.45
Extreme 18.45
46.75
10 years 16.05
Extreme 16.05
46.75
Manager TitleAgeSince
Chief Executive Officer 51 2025-06-30
Director of Finance/CFO - 2024-09-29
Chief Tech/Sci/R&D Officer - 2024-08-04
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 2019-06-30
Director/Board Member 60 2021-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
9/18/26 Buy

Director

27 0.0000%
9/18/26 Buy

Director

160 0.0001%
9/18/26 Buy

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.05%+2.44%-26.83%-43.24% 2.46B
+4.28%+0.07%+52.75%+138.78% 1,206B
+2.13%+4.27%+51.21%+91.36% 665B
+0.68%+1.54%+33.83%+112.47% 515B
+2.77%-0.57%+49.44%+68.42% 381B
+1.38%+0.27%+72.42%+45.30% 362B
+0.29%-0.24%+30.84%+57.23% 307B
+0.98%+1.49%+9.04%+34.78% 289B
+1.04%-0.05%+45.29%+76.18% 249B
+1.46%-0.59%+42.48%+125.82% 207B
Average +1.33%+0.11%+36.05%+70.71% 418B
Weighted average by Cap. +2.29%+0.65%+45.95%+95.88%

Financials

2027 *2028 *
Net sales 14.02B 17.25B 9.68B 8.64B 7.95B 7.22B 13.68B 908B 95.14B 37.92B 486B 36.34B 35.57B 1,530B 14.63B 18B 10.1B 9.02B 8.3B 7.53B 14.27B 947B 99.27B 39.57B 507B 37.92B 37.11B 1,597B
Net income 228M 280M 157M 140M 129M 117M 222M 14.74B 1.54B 616M 7.89B 590M 577M 24.85B 263M 324M 182M 162M 149M 136M 257M 17.05B 1.79B 712M 9.13B 683M 668M 28.75B
Net Debt 1.01B 1.25B 701M 625M 575M 522M 990M 65.67B 6.88B 2.74B 35.16B 2.63B 2.57B 111B 976M 1.2B 674M 602M 554M 502M 952M 63.17B 6.62B 2.64B 33.82B 2.53B 2.48B 107B
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
26-11-09 NZ$21.00 -2.05% 77,976
26-11-06 NZ$21.44 -1.11% 84,872
26-11-05 NZ$21.68 +0.93% 106,196
26-11-04 NZ$21.48 +0.14% 232,327
26-11-03 NZ$21.45 +0.75% 167,847
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.07AUD
Average target price
23.04AUD
Spread / Average Target
+35.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited